Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Reiterates Overweight Rating on Pfizer (PFE) Following 4Q

January 29, 2020 7:04 AM
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $53.00 price target on Pfizer (NYSE: PFE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View

Next Articles